Clinical Trial Update: OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis [NA]

View source ↗

Summary

A clinical trial update evaluating how unfractionated heparin and low-molecular-weight heparin during hemodialysis affect plasma levels of osteoprotegerin (OPG)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Renal Failure

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Renal Failure, Hemodialysis | NA | Status: UNKNOWN